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γδ T cells have emerged as key providers of interleukin 17 (IL-17) in 
various models of infection, inflammation and autoimmunity1–6. 
Antibody-mediated or genetic depletion of γδ T cells greatly reduces 
disease severity in IL-17-driven models of chronic inflammation1–4,7. 
Those results notwithstanding, many reports have made a compelling 
case for γδ T cells as major producers of interferon-γ (IFN-γ) in both 
mice and humans8, which has been a foundation for clinical trials target-
ing these lymphocytes in cancer immunotherapy9. Given the dual ability 
of γδ T cells to produce IL-17 and IFN-γ, published work has aimed 
to identify markers associated with functional attributes of mouse γδ  
T cells10–13. Expression of the costimulatory receptor CD27 segregates 
IL-17-producing (CD27−) γδ T cells and IFN-γ-producing (CD27+) γδ 
T cells in both naive and Plasmodium-infected C57BL/6 mice10. Moreover, 
the chemokine receptor CCR6, which is expressed exclusively on CD27− 
γδ T cells, constitutes an additional marker for IL-17+ γδ T cells13,14.
Both CD27+ and CD27− γδ T cell subsets show spontaneous 
cytokine secretion after activation, in contrast to the delayed differ-
entiation of conventional CD4+ T cells of the TH1 or TH17 subset 
of helper T cells15. That finding is highlighted by the observation 
that 30–40% of peripheral γδ T cells freshly isolated from naive mice 
produce either IL-17 or IFN-γ after 3 h of restimulation in vitro10. 
Those functionally mature γδ T cell subsets are also found in the thy-
mus as early as the embryonic stages of mouse development10–12,16. 
Moreover, the expression of genes linked to the production of IL-17 or 
IFN-γ segregates with particular γδ thymocyte subsets17. However, the 
epigenetic ‘landscape’ of γδ T cells, which, as for CD4+ T cells18,19, prob-
ably dynamically controls the expression of genes encoding signature 
cytokines and their transcriptional regulators, remains unknown. 
Among other epigenetic mechanisms, methylation of histone H3 at 
Lys4 (H3K4me) or Lys27 (H3K27me) controls the accessibility of 
genes for the transcriptional machinery and thereby regulates cell 
fate19. Notably, the advent of deep (massive) sequencing, coupled to 
chromatin immunoprecipitation (ChIP), has allowed the genome-
wide characterization of H3K4- and H3K27-methylation patterns in 
various cell types, including CD4+ helper T cell subsets that were 
differentiated in vitro18.
To gain insight into the epigenetic regulation of γδ T cell subsets, 
we conducted genome-wide profiling of active dimethylated H3K4 
(H3K4me2) and repressive trimethylated H3K4 (H3K4me2) modifi-
cations, complemented with analysis of additional chromatin marks 
(H3K36me3 and H3 acetylation) and transcriptional quantification of 
CD27+ γδ (γδ27+) T cell or CD27− γδ (γδ27−) T cell subsets isolated 
from secondary lymphoid organs and compared those with the histone 
modifications and mRNA abundance in TH1 or TH17 CD4+ T cells 
differentiated in vitro. Our results constitute a public resource describ-
ing the epigenomes of γδ27+ and γδ27− T cells and their effect on key 
transcriptional regulators of differentiation, and provide new insights 
on the peripheral functions of thymus-derived γδ T cell subsets.
RESULTS
Genome-wide analysis of H3 methylation in gd T cell subsets
To obtain a global profiling of chromatin modifications in γδ T cell 
subsets (isolated from pooled lymph nodes and spleen), we analyzed 
those cells by ChIP with antibody to H3K4me2 (anti-H3K4me2) and 
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Two distinct subsets of gd T cells that produce interleukin 17 (IL-17) (CD27− gd T cells) or interferon-g (IFN-g) (CD27+ gd 
T cells) develop in the mouse thymus, but the molecular determinants of their functional potential in the periphery remain 
unknown. Here we conducted a genome-wide characterization of the methylation patterns of histone H3, along with analysis of 
mRNA encoding transcription factors, to identify the regulatory networks of peripheral IFN-g-producing or IL-17-producing gd  
T cell subsets in vivo. We found that CD27+ gd T cells were committed to the expression of Ifng but not Il17, whereas CD27− gd 
T cells displayed permissive chromatin configurations at loci encoding both cytokines and their regulatory transcription factors 
and differentiated into cells that produced both IL-17 and IFN-g in a tumor microenvironment.
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anti-H3K27me3, followed by deep sequencing (ChIP-seq). As ref-
erence, we differentiated CD4+ TH1 and TH17 subsets by standard 
in vitro protocols and subjected those to the same ChIP-seq analysis. 
This confirmed published observations of TH1-biased Ifng expres-
sion and H3K4me2 marks in the Ifng locus18, which contrasted with 
the expression and H3K4me2 modifications of Il17a in TH17 cells 
(Supplementary Fig. 1).
We subjected the ChIP-seq data to in-depth bioinformatics analy-
sis. We used three different ‘peak-calling’ tools to detect enrichment 
for histone-modification density and assigned only peaks consistently 
retrieved by all three methods. We first examined the H3-methylation 
patterns, across the entire genome, in the total pool of T cell subsets 
under study: γδ27+ and γδ27− T cells, and TH1 and TH17 cells. This 
revealed that the vast majority (95%) of all H3-modified genes (in the 
total pool of T cell subsets) displayed the H3K4me2 or H3K27me3 
marks in the promoter-proximal region (1 kilobase (kb) upstream 
and downstream of transcription start site); we observed only a small 
increase in H3 modifications when we also considered the distal pro-
moter region (Fig. 1a). High proportions of H3-modified genes were 
associated with H3K4me2 alone (50%) or with both H3K4me2 or 
H3K27me3 marks (27%), with similar patterns observed for all four 
T cell subsets (Fig. 1b). A smaller fraction of H3-modified genes 
(<18%) displayed repressive H3K27me3 marks alone (Fig. 1b), with 
4% (883 genes) of all H3-modified genes displaying only H3K27me3 
marks concomitantly in all four T cell subsets (Fig. 1c). Quantitative 
analysis of the genes marked by H3K4me2 alone, H3K27me3 alone 
or both H3K4me2 and H3K27me3 revealed that from an epigenetic 
perspective, the γδ27+ and γδ27− T cell subsets generated in vivo were 
as distinct from each other as were the CD4+ TH1 and TH17 cells 
subsets polarized in vitro (Fig. 1d).
We next focused our analysis on the two γδ T cell subsets and com-
pared the H3-methylation densities of γδ27+ and γδ27− T cells. On 
the basis of quantitative algorithms, a total of 10,581 genes had a dif-
ference in the abundance of either H3K4me2 or H3K27me3 marks 
(Fig. 2a,b). Those marks were located in the promoter-proximal 
region for 64% of all genes with a difference in H3 modification in 
γδ27+ T cells versus γδ27− T cells (Fig. 2a).
Selective inspection of the epigenetically regulated genes in γδ27+ 
and γδ27− T cell subsets indicated that genes linked to (γδ) T cell 
development (such as Bcl11b, Id3 or Etv5)17 displayed almost identical 
histone marking in both subsets (Fig. 2c). In contrast, genes encod-
ing effector cytokines (Il17a, Il17f and Il22) showed substan-
tially more enrichment for permissive H3K4me2 marks in γδ27−  
T cells than in γδ27+ T cells (Fig. 2c). These epigenetic profiles sug-
gested that γδ27+ and γδ27− T cells share an early developmental 
program but diverge during functional differentiation into cytokine-
producing subsets.
Additional targets in the differentiation of gd T cell subsets
We next examined the full H3K4me2-H3K27me3 epigenome of 
γδ27+ and γδ27− T cells (Supplementary Table 1) to identify genes 
encoding molecules involved in their differentiation. Il17a, Il17f and 
Il22 were among the genes with the greatest difference between the 
two subsets in H3 modification, and all showed more enrichment 
for active H3K4me2 marks in γδ27− T cells than in γδ27+ T cells 
(Supplementary Table 2). We noted the same pattern for Ccr6 (which 
encodes the chemokine receptor CCR6) and Il1r1 and Il23r (which 
encode cytokine receptors) (Supplementary Table 2), all known to 
be expressed in γδ27− cells1,13,14,20. Those results notwithstanding, 
the 25 genes with the greatest difference in modification in γδ27+  
T cells versus γδ27− T cells represented previously unknown targets 
for the development and function of γδ T cells (Supplementary 
Table 2). Dock8 and Dkk3 displayed active H3K4me2 marks in γδ27− 
T cells but not in γδ27+ T cells. The guanine-exchange factor DOCK8 
is a signaling adaptor that controls the survival and function of CD8+ 
T cells21 and activation of B cells22. Moreover, DOCK8 mutation 
in humans causes severe combined immunodeficiency associated 
with high susceptibility to infection21,22. DKK3 is a glycoprotein 
that modulates Wnt signaling and has a regulatory function in 
CD8+ T cells23.
While our analysis revealed many signaling mediators and 
transcription factors of unknown function in γδ T cells (or T cells 
in general), various candidates were among the proteins with recep-
tor activity (Supplementary Table 2): the costimulatory receptor 
SLAMF1 (CD150), which controls the development of natural killer 
(NK) T cells24 and promotes inflammation in a mouse model of 
colitis25; the scavenger receptor SCARF1, which recognizes and trig-
gers innate immune responses to fungi26; EPHB2, which orchestrates 
c
TH1
475
141
281 362
520
599
164
516673
3147931
186
269
678
114
TH17
γδ27+ γδ27
–
H3K4me2 only
TH1
506
306
900
363
265
571
489
229883
191
176
152 718
60
222
TH17
γδ27+ γδ27–
H3K27me3 only
TH1
448
112
631 648
354
326
237
156 64
2877
242
532
285
124
1012
TH17
γδ27+ γδ27–
H3K4me2 + H3K27me3
d
G
en
es
 w
ith
 d
iff
er
en
t H
3
m
od
ifi
ca
tio
n 
(%
)
H3K4me2 only
H3K4me2 + H3K27me3
H3K27me3 only
80
T H
1 
vs
 T H
17
γδ2
7
+ vs
 γδ
27
–
60
40
20
0
G
en
es
 w
ith
 h
is
to
ne
m
od
ifi
ca
tio
n 
(×
10
3 )
b
10
H3K4me2 only
H3K4me2 + H3K27me3
H3K27me3 only
None
6
2
0
TH1 TH17γδ27
+ γδ27–
a
H3K4me2
G
en
es
 w
ith
 h
is
to
ne
m
od
ifi
ca
tio
n 
(×
10
3 )
25 H3K27me3 Both
20
15
10
5
0
Prox prom
Int body
Gene
Dist prom + gene
Figure 1 Genome-wide histone H3 methylation in subsets of γδ T cells and CD4+ helper T cells. (a) ChIP-seq quantification 
of genes associated with H3K4me2 or H3K27me3 alone or H3K4me2 and H3K27me3 together (Both) in the total pool  
of γδ27+ T cells, CCR6+ γδ27− γδ T cells and CD4+ TH1 and TH17 cells, in the following genomic regions: distal promoter 
(−4 kb to −1 kb upstream of the transcription start site) plus gene (Dist prom + gene); proximal promoter (−1 kb to  
+1 kb around the transcription start site; Prox prom); internal gene body (+1 kb from the start site to end of gene; Int body); 
and the gene (proximal promoter + internal gene body; Gene). (b) ChIP-seq quantification of genes associated with histone 
modifications as in a in each of the four T cell subsets in a. (c) Overlap of genes associated with histone modifications in 
the four T cell subsets in a, presented as Venn diagrams. (d) Frequency of genes with differences in modification in γδ27+ 
T cells versus (vs) γδ27− T cells (left) or TH1 cells versus TH17 cells (right) among those with H3K4me2 or H3K27me3 
modifications or both H3K4me2 and H3K27me3 modifications. Samples were analyzed a second time to ensure the 
technical reproducibility of ChIP-seq results; results were confirmed by ChIP-qPCR analysis of biological duplicates. Data 
are from one experiment with cells pooled from eight mice.
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Epigenetic control of cytokine expression in gd T cell subsets
We next focused on the epigenetic regulation of genes encoding signa-
ture cytokines in the two γδ T cell subsets. In contrast to Il17a, IL17f 
and Il22 (Supplementary Table 2), Ifng did not show a difference in 
H3 methylation in γδ27+ T cells versus γδ27− T cells (Supplementary 
Table 1). Individual ChIP-seq profiles showed that Il17a (Fig. 4a) 
and Il17f and Il22 (Supplementary Fig. 3a) accumulated many active 
H3K4me2 marks in γδ27− T cells but not in γδ27+ T cells, whereas the 
Ifng locus displayed H3K4me2 marks in both γδ cell subsets (Fig. 4a). 
ChIP followed by quantitative PCR (ChIP-qPCR) with primers for the 
respective promoters and other known regulatory conserved non-
coding sequences31–33 confirmed accumulation of active H3K4me2 
marks in the Ifng locus in both γδ27+ T cells and γδ27− T cells in the 
periphery (Fig. 4b and Supplementary Fig. 3b,c) and in the thymus 
(Fig. 4c). The segregation of repressive H3K27me3 marks in γδ27+  
T cells versus γδ27− T cells was less obvious at loci encoding the 
signature cytokines, by both ChIP-seq (Fig. 4a and Supplementary 
Fig. 3a) and ChIP-qPCR (Supplementary Fig. 4).
We also investigated additional histone modifications that associ-
ate with gene expression. Acetylation of histone H3 has been linked 
to the expression of genes important for the differentiation of helper 
T cells31,34. ChIP-qPCR of γδ27+ and γδ27− T cells, with primers 
specific for the Ifng and Il17a promoters, showed the presence of 
acetylated H3 marks at the Il17a locus exclusively in γδ27− cells, while 
these permissive marks were of almost identical abundance at the Ifng 
locus in both γδ T cell subsets (Fig. 4d).
To evaluate the effect of those histone-modification patterns on 
the expression of cytokine-encoding genes, we measured Ifng and 
Il17a mRNA by reverse transcription followed by quantitative PCR 
(quantitative RT-PCR). Consistent with the epigenetic data, Il17a 
had ~700-fold higher expression in peripheral γδ27− T cells than in 
peripheral γδ27+ T cells, while Ifng had ~10-fold higher expression in 
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Figure 2 Peripheral γδ27+ and γδ27− T cells display distinct genome-wide histone 
H3 methylation patterns. (a) ChIP-seq quantification of genes associated with 
differences in H3K4me2 or H3K27me3 histone modifications in the full gene 
or the proximal promoter region (as defined in Fig. 1a) in peripheral γδ27+ and 
γδ27− T cells. (b) Histone-modification profiles of genes with a greater abundance 
of H3K4me2 or H3K27me3 in γδ27+ or γδ27− T cells; the 5′ and 3′ ends are 
‘unscaled’, and the remainder of the gene is rescaled to 2 kb; long gray vertical 
lines correspond to gene regions along horizontal axes; gray shading indicates 
error bars. TSS, transcription start site. (c) Quantification (log10-transformed) of 
H3K4me2 and H3K27me3 modifications of genes linked to T cell development 
(top) or of signature cytokine–encoding genes (bottom), in γδ27+ or γδ27− T cells. 
Reproducibility and ChIP-qPCR, as in Figure 1. Data are from one experiment with 
cells pooled from eight mice.
the crosstalk between thymocytes and thymic epithelial cells and thus 
affects early T cell development27; Flt1, which binds vascular endothelial 
growh factor A and costimulates IFN-γ production28; and OX40 
(TNFRSF4), a costimulator of CD4+ and CD8+ T cells, as well as 
NK and NKT cells29, although its role in the activation of γδ T cells 
remains unclear. The only chemokine receptor–encoding gene other 
than Ccr6 with substantially different modification in γδ27− T cells 
versus γδ27+ T cells was Ccr1 (Supplementary Table 2); CCR1 has 
been linked to the migration of macrophages and neutrophils30 but 
not T cells.
Six of those eight candidates also had a difference in H3K4me2 mod-
ification in thymic γδ27− T cells versus γδ27+ T cells (Supplementary 
Fig. 2). Except for Ccr1, those genes had a greater abundance of 
H3K4me2 marks in peripheral γδ T cell subsets than in thymic γδ 
T cell subsets (Supplementary Fig. 2). This suggested that the epi-
genetic segregation of the gene-expression programs of γδ27− and 
γδ27+ T cells starts in the thymus but is further consolidated as cells 
continue to mature in the periphery.
We did preliminary analysis of the expression of Dkk3 and Slamf1 
on γδ T cells and assessed the effect of their deletion on the differen-
tiation and function of γδ T cells. γδ27− T cells showed considerable 
enrichment for Dkk3 mRNA and SLAMF1 protein relative to their 
abundance in γδ27+ T cells (Fig. 3a,b). SLAMF1 was coexpressed 
with CCR6 in the thymus and in the periphery (Fig. 3b) and thus 
constitutes an additional marker for the CD27−CCR6+ γδ T cell sub-
set10,13,14. Whereas we observed no difference between Slamf1−/− 
and wild-type mice in their production of IL-17, Dkk3−/− mice 
displayed greater frequencies of peripheral IL-17-producing γδ27−  
T cells than did wild-type mice (Fig. 3c). In contrast, IL-17 expres-
sion was normal in Dkk3−/− TH17 cells (Fig. 3d), and IFN-γ produc-
tion was not altered in Dkk3−/− γδ27+ or TH1 cells (data not shown). 
These data suggested a role for DKK3 in selectively regulating IL-17 
production in γδ27− T cells. Thus, this analysis has provided a set of 
potential additional regulators of the differentiation and activation 
of γδ T cells, some of which may also be shared with CD4+ helper 
T cells (Supplementary Table 2).
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of genes encoding signature cytokines in γδ T cells is epigenetically 
patterned in the thymus and is sustained in peripheral γδ T cell sub-
sets and revealed a distinct degree of polarization toward TH1-like or 
TH17-like effector function among γδ T cell subsets.
Epigenetic patterning of TH1 versus TH17 factors in gd T cells
We next analyzed our ChIP-seq data for (mostly transcription) factors 
that have been linked to the differentiation of TH1 or TH17 cells15 
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Figure 3 DKK3 and SLAMF1 are molecular  
determinants of γδ27− T cells. (a) Quantitative  
RT-PCR analysis of Dkk3 expression in ex vivo  
CD4+ T cells (Naive splenic CD4+), γδ27+  
T cells and γδ27− T cells (sorted from peripheral  
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(b) Surface expression of SLAMF1 (CD150), CD27 and CCR6 on  
total γδ T cells from cutaneous lymph nodes (LN (cut); left) and  
thymus (right), assessed by flow cytometry. Numbers in quadrants  
indicate percent cells in each throughout. (c) Intracellular staining  
of IFN-γ and IL-17A in γδ27− cells isolated from groups of C57BL/6  
wild-type (WT), Dkk3−/− and Slamf1−/− mice (left), and frequency of  
IL-17+ γδ27− T cells in those mouse strains (right). (d) Intracellular  
staining of IFN-γ and IL-17A in TH17 cells differentiated in vitro  
from CD4+ T cells isolated from wild-type, Dkk3−/− and Slamf1−/− mice.  
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two independent experiments with one mouse per strain in each (d).
γδ27+ T cells than in γδ27− T cells (Fig. 4e). Moreover, Il17f and Il22 
were also overexpressed in γδ27− T cells (Supplementary Fig. 3d). 
We also found similar differences for thymic γδ T cell subsets, in 
which the difference in expression was ~2-fold for Ifng and >200-fold 
for Il17a (Fig. 4f) and Il22 (data not shown). Of note, in the thymus, 
Ifng and Il17a transcripts were expressed only in γδ T cells and were 
almost undetectable in αβ thymocytes (Fig. 4f). Both Ifng and Il17a 
were expressed in CD25+ γδ thymocytes, which represent a common 
progenitor population for both γδ27− and γδ27+ T cells10, followed 
by further upregulation of Ifng in γδ27+ T cells and of Il17a in γδ27− 
thymocytes (Fig. 4f). These data demonstrated that the expression 
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Figure 4 Epigenetic and transcriptional patterning of Ifng and Il17a in γδ T cell subsets. (a) ChIP-seq analysis of H3K4me2 (green) and H3K27me3 
(black) modifications on Ifng and Il17a in peripheral γδ27+ and γδ27− T cells; below, chromosome (Chr) locations and exon positions (black boxes). 
(b,c) ChIP-qPCR analysis of H3K4me2 modifications on Ifng (promoter (Prom) and conserved noncoding sequence −34 regions (CNS–34)) and Il17a 
(promoter (Prom) and conserved noncoding sequence +5 regions (CNS+5)) in peripheral (b) or thymic (c) γδ27+ and γδ27− T cells; results are presented 
relative to total H3. (d) ChIP-qPCR analysis of total acetylated histone H3 in the promoter regions of Ifng or IL17a in peripheral γδ27+ and γδ27−  
T cells (presented as in c). (e) Quantitative RT-PCR analysis of the expression of Ifng and Il17a in CD4+, γδ27+ and γδ27− T cells from pooled spleen 
and lymph nodes of C57BL/6 mice (e) and in CD4+CD8+ double-positive (DP) and CD4+ single-positive (SP CD4) thymocytes of the αβ T cell lineage 
and CD25+CD27+ (γδ25+), CD25− γδ27+ and CD25− γδ27− thymocytes of the γδ T cell lineage (e), presented relative to Actb expression. Each symbol 
(e,f) represents an individual experiment. *P < 0.05 and **P < 0.001 (Mann-Whitney two-tailed test). Data are from one experiment with cells pooled 
from eight mice (a–d) or eight independent experiments with cells pooled from four mice in each (e,f; mean and s.d. in b–d).
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or, in some instances, specifically to the differentiation of cytokine-
producing γδ T cells35,36. For simplicity, here we have designated 
the regulators of IFN-γ or IL-17 production (in either CD4+ or γδ 
T cells) ‘TH1 factors’ or ‘TH17 factors’, respectively. Examination 
of individual ChIP-seq profiles (Fig. 5a) or their global activity 
(Fig. 5b) revealed TH17 polarization of γδ27− T cells but not of γδ27+ 
T cells, indicated by the accumulation of permissive H3K4me2 marks 
in genes encoding differentiation factors, such as Rorc, Rora or Batf 
(Fig. 5a,b), as well as in the cytokine receptor–encoding genes 
Il1r1 and Il23r1,20 and the chemokine receptor–encoding gene Ccr6  
(ref. 13) (Supplementary Fig. 5a). Moreover, Rorc and Blk (Fig. 5a) 
and Maf and Irf4 (data not shown) displayed repressive H3K27me3 
modifications in γδ27+ T cells but not in γδ27− T cells. In contrast, 
most genes encoding TH1-differentiation factors (such as Tbx21, 
Eomes and Hlx) were positively marked by H3K4me2 in both γδ  
T cell subsets, and some (Eomes and Hlx) also displayed substantial 
repressive H3K27me3 modification in both γδ T cell subsets (Fig. 5a). 
As reference, genes encoding molecules associated with cell survival, 
the development of γδ T cells or alternative T cell effector functions 
did not show a difference in H3 modification in the two γδ T cell 
subsets (Fig. 5b and data not shown).
To further document the epigenetic regulation of important tran-
scription regulators in γδ T cell subsets, we analyzed the H3K36me3 
marking of the Tbx21, Eomes and Rorc loci. H3K36me3 modifications, 
which accumulate at the 3′ end of genes, correlate with transcriptional 
activity in intron-containing genes37. The two γδ T cell subsets showed 
a difference of less than threefold in the H3K36me3 marking of 
Tbx21 or Eomes, whereas the Rorc locus had more than tenfold more 
H3K36me3 marking in γδ27− T cells than in γδ27+ T cells (Fig. 5c). 
The difference in the patterning of TH1 or TH17 factors in peripheral 
γδ T cell subsets extended to the transcriptional level, as by quantita-
tive RT-PCR analysis we estimated the abundance of Rorc transcripts 
was ~600-fold greater in γδ27− T cells than in γδ27+ T cells, whereas 
the abundance of Tbx21 and Eomes was only slightly (four- to sixfold) 
greater in γδ27+ T cells (Fig. 5d). Furthermore, H3K4me2 modifica-
tions of the Ifng promoter in γδ27+ T cells were similar in wild-type 
and Tbx21−/− mice (Supplementary Fig. 6), and Tbx21−/− mice had a 
substantial proportion of IFN-γ-producing γδ T cells (Supplementary 
Fig. 7a,b). In contrast, Rorc−/− mice lacked the CCR6+ (γδ27−) T cell 
subset in both the thymus and spleen (Supplementary Fig. 7c) and 
did not express IL-17A in total γδ T cells (Supplementary Fig. 7d).
Although the expression of many TH1 factors versus that of TH17 
factors segregated with the two peripheral γδ T cell subsets (Fig. 5e), 
the transcriptional polarization was much stronger for the TH17 pro-
gram (Fig. 5d,e). That was consistent with the accumulation of repres-
sive H3K27me3 marks at TH17-related loci, such as Rorc, Blk and Maf 
(Fig. 5a and data not shown), in γδ27+ T cells. Of note, the expression 
of Rorc, Rora and Maf was higher in γδ27− T cells ex vivo than in TH17 
cells generated in vitro (Fig. 5d), and overall there was better segrega-
tion of TH17 transcription factors in γδ T cells than in CD4+ helper 
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Figure 5 Permissive histone H3 methylation  
patterns associate with transcription of TH1-  
and TH17-related factors in γδ T cell subsets.  
(a) ChIP-seq analysis of H3K4me2 (green)  
and H3K27me3 (black) modifications on  
genes encoding TH1-related factors (Tbx21,  
Eomes, Hlx; left) and TH17-related factors  
(Rorc, Batf, Blk; right) in peripheral γδ27+  
and γδ27− T cells (below plots, as in Fig. 4a). (b) Quantification (log10-transformed) of gene-specific H3K4me2 modifications on genes in γδ27+ T cells 
and γδ27− T cells for genes grouped as TH1- and TH17-related factors (top left), genes linked to γδ T cell development (top right), genes associated 
with alternative effector cell types (bottom left) and housekeeping reference or survival genes (bottom right). (c) ChIP-qPCR analysis of H3K36me3 
modifications on Tbx21, Eomes, and Rorc in γδ27+ and γδ27− T cells, presented relative to the abundance of total H3. (d) Quantitative RT-PCR 
analysis of genes encoding TH1-related factors (top) and TH17-related factors (bottom) on ex vivo CD4+ T cells and γδ27+ and γδ27− T cells (derived 
from peripheral T cells) and CD4+ TH1 and TH17 cells generated in vitro, presented relative to Actb expression. NS, non significant; *P < 0.05 (Mann-
Whitney two-tailed test). (e) Expression of TH1- and TH17-associated genes (from data in d) in γδ27+ T cells versus γδ27− T cells (top) or CD4+ TH1 cells 
versus TH17 cells (bottom). Each symbol (d,e) represents an individual experiment (d) or the mean of the data in d (e). Data are from one experiment 
with cells pooled from eight mice (a–c) or five independent experiments with cells pooled from four mice in each (d,e; mean and s.d. in c,e).
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T cell subsets (Fig. 5e). These data documented distinct epigenetic 
patterning and transcriptional regulation of TH1 factors versus TH17 
factors in γδ T cell subsets and showed that both γδ27+ and γδ27−  
T cells had TH1 factors epigenetically primed for expression.
Stable versus plastic differentiation of gd T cell subsets
In line with the epigenetic status of Ifng and the genes encoding TH1 
factors described above, γδ27− T cells stimulated in vitro are reported 
to produce both IL-17 and IFN-γ10. To further explore the conditions 
that trigger IFN-γ production in those cells, we established short-term 
cultures of highly purified γδ27− or γδ27+ T cells in cytokine-defined 
media. γδ27− T cells responded to IL-1β and IL-23 by acquiring IFN-γ 
production, which resulted in a sizeable population of cells that 
produced both IL-17 and IFN-γ (Fig. 6a,b). The differentiation of 
γδ27− T cells into cells that produced both IL-17 and IFN-γ was neg-
ligible under TH17-differentiation conditions (Fig. 6a,b), whereas 
TH1-differentiation conditions did not support the survival of γδ27− 
T cells (Supplementary Fig. 8). Furthermore, γδ27+ T cells stably and 
exclusively produced IFN-γ, even under TH17 conditions (Fig. 6a). Of 
note, stimulation with IL-1β and IL-23 resulted in the death of γδ27+ 
cells (Supplementary Fig. 8), consistent with their lack of expression 
of the corresponding receptors (Supplementary Fig. 5).
Finally, we sought to determine if the plasticity of γδ27−  
T cells was detectable in vivo. To investigate whether the systemic 
immune response to infection could drive the differentiation of 
IL-17+IFN-γ+ γδ T cells, we set up in vivo infection models based 
on four distinct types of microorganisms that elicit γδ T cell 
responses10,20: a parasite (Plasmodium berghei), a virus (murid herpes 
virus 4), a bacterium (Mycobacterium avium) and a fungus (Candida 
albicans). We isolated cells from the spleen and lymph nodes at the 
peak of each γδ T cell response. However, we did not observe substan-
tial populations of IL-17+IFN-γ+ γδ T cells in these acute infection 
models (Supplementary Fig. 9).
We reasoned that a strong local inflammatory response might be 
necessary for the differentiation of IL-17+IFN-γ+ γδ T cells in vivo. 
We therefore transplanted an ovarian cancer cell line (ID8) known 
to produce a highly inflammatory microenvironment38 into the peri-
toneal cavity of mice and monitored the growth of ID8 tumor cells 
(transfected with a plasmid bearing a luciferase reporter–encoding 
gene) by bioimaging techniques38 (data not shown). We observed the 
accumulation of a sizeable population of IL-17+IFN-γ+ γδ T cells after 
tumor growth (at 6 weeks; Fig. 6c). Those IL-17+IFN-γ+ T cells were 
CD27−, unlike the IFN-γ+ γδ T cells (Fig. 6d). In fact, IL-17+IFN-γ+ 
cells constituted up to 30% of the γδ27− T cell subset present in the 
tumor-bearing peritoneal cavity (Fig. 6e). In contrast, γδ27+ T cells 
remained exclusive producers of IFN-γ (Fig. 6d). These data dem-
onstrated that the plasticity of γδ27− T cells, which is in contrast to 
the stable phenotype of the γδ27+ T cells, was triggered under spe-
cific local inflammatory conditions and may thus contribute to their 
function in vivo.
DISCUSSION
Epigenetic mechanisms ensure the autonomous maintenance of line-
age phenotype in differentiated cells, even through mitotic divisions. 
Methylation patterns of active H3K4 and repressive H3K27 have been 
shown to affect the functional (in)stability of effector CD4+ helper 
T cell subsets18,32,39. Here we have described the epigenetic landscape 
of TH1- and TH17-related loci in γδ T cells freshly isolated from lym-
phoid organs. Through the use of genome-wide ChIP-seq analysis, we 
have identified many potential previously unknown participants in 
the differentiation and activation of γδ T cell subsets. Notably, among 
the top genes selected on the basis of their differences in histone H3 
marking in γδ27+ versus γδ27− T cell subsets, only a minority (40 of 
120) were also different in CD4+ TH1 versus TH17 subsets. This sug-
gested that different lineage-specific mechanisms of differentiation 
might operate in γδ T cells, as exemplified by DKK3.
DKK3 is a secreted glycoprotein that modulates Wnt signaling and 
whose expression is often epigenetically silenced in a variety of cancer 
cell types, which suggests a potential role as a tumor suppressor40. 
Although little is known about the functions of DKK3 in the immune 
Figure 6 Differentiation of IL-17+IFN-γ+ 
γδ27− cells in vitro and in vivo.  
(a) Intracellular staining of IFN-γ and  
IL-17A in γδ27+ and γδ27− T cells isolated 
from pooled spleen and lymph nodes and 
stimulated in vitro for 48 h in the presence of 
IL-1β plus IL-23 or standard TH1- or TH17-
polarizing conditions. ND, not determined 
(lack of cell viability; Supplementary Fig. 8). 
(b) Frequency of IL-17A+IFN-γ+ cells in the 
cultures in a, normalized to the proportion  
of live cells (Supplementary Fig. 8).  
(c) Intracellular IFN-γ and IL-17A (right) in 
total γδ T cells (gated at left) from peritoneal 
exudates obtained at 2 or 6 weeks of the 
development of ID8 tumors in C57BL/6 mice. 
Numbers adjacent to outlined areas indicate 
percent γδ T cells (right column), or IFN-γ+ γδ 
T cells (top left), IL-17A+ γδ T cells (bottom 
right) or IFN-γ+IL-17A+ γδ T cells (top right; 
all left column). (d) Overlay of the surface 
staining of CD27 on IL-17A+, IL-17A+IFN-γ+ 
or IFN-γ+ γδ T cells from peritoneal exudates 
at 6 weeks of ID8 tumor development  
(as in c). (e) Frequency of IL-17A+IFN-γ+  
cells among CD27− γδ T cells (as in c,d).  
Each symbol (b,e) represents an individual experiment. *P < 0.05 and **P < 0.01 (Mann-Whitney two-tailed test). Data are representative of four to 
six independent experiments (a,b) or two independent experiments with four mice in each (c–e).
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system, it is reported to have a powerful regulatory function in CD8+ 
T cells23. DKK3 is expressed in transgenic CD8+ T cells tolerized in 
the neonatal period through interactions with a self antigen expressed 
in keratinocytes (in a double-transgenic mouse model) and is neces-
sary and sufficient for maintenance of CD8+ T cell tolerance in this 
model. In particular, Dkk3−/− mice reject autologous skin grafts and 
readily eradicate transplantable tumors23. Notably, published studies 
have suggested a general absence of Dkk3 expression on T cell subsets, 
except for a specific subset of long-term memory CD8+ T cells41. Our 
findings have extended Dkk3 expression to the γδ27− T cell subset 
while excluding it from γδ27+ T cells and CD4+ helper T subsets. 
Furthermore, Dkk3−/− γδ27− T cell populations showed enrichment 
for cells that produced IL-17, which selectively linked DKK3 to the 
functional differentiation of this γδ T cell subset.
Although the mechanisms of action of DKK3 remain unclear, it 
is widely regarded as an inhibitor of the Wnt signaling cascade40. 
Notably, the downstream (transcriptional) effectors of Wnt signal-
ing, TCF1 and Lef, have been shown to inhibit the differentiation of 
IL-17-producing γδ T cells42. Moreover, in our ChIP-seq analyses, Tcf7 
(which encodes TCF1) and Lef were biased toward γδ27+ T cells (albeit 
below the eightfold threshold that was the inclusive criteria we used 
here): Lef1 displayed a 6.4-fold enrichment for active H3K4me2 marks 
in γδ27+ T cells and 4.8-fold enrichment for repressive H3K27me3 
marks in γδ27− T cells; and Tcf7 showed a 4.5-fold accumulation of 
H3K27me3 marks in γδ27− T cells. Given the increased production of 
IL-17 by Dkk3−/− γδ27− T cells, these data suggested crosstalk between 
DKK3 and Wnt signaling during the differentiation of γδ T cells that 
warrants further investigation.
As functional differentiation of γδ T cells can occur in the 
thymus10–12, the stability of cellular phenotypes in the periphery prob-
ably depends on the epigenetic patterning of key (master) transcrip-
tion factors. Our data showed that Tbx21 and Eomes (which encode 
TH1-related transcription factors) and Rorc and Batf (which encode 
TH17-related transcription factors) were distinctively patterned 
(by histone H3 modifications) in the γδ27+ versus γδ27− subsets, and 
this was associated with their mRNA expression. Notably, genetic 
deletion of Tbx21 or Rorc (data not shown) did not impair the epige-
netic marking of the respective signature cytokine–encoding genes 
Ifng and Il17. That was consistent with studies showing that T-bet 
(encoded by Tbx21) has very modest effect on the active enhancer 
repertoire of CD4+ TH1 cells43. That result notwithstanding, our data 
cannot exclude the possibility that histone patterning of Ifng or Il17 
in γδ T cell subsets is controlled by unknown combinations of TH1- 
or TH17-related transcriptional regulators. Of note, members of the 
STAT family of transcription factors have a critical role in shaping 
the epigenetic landscape of TH1, TH2 and TH17 cells18,43,44. Although 
the role of STAT1 and STAT4 in the differentiation of IFN-γ+ γδ  
T cells requires further investigation, STAT3 is largely dispensable 
for the generation of IL-17-producing γδ T cells45. That is consist-
ent with their independence of IL-6 signals46 and illustrates how 
the developmental programming of γδ T cells (in the thymus) 
follows rules distinct from those of CD4+ T cell differentiation after 
activation (by signaling via the T cell antigen receptor and cytokines) 
in the periphery.
While our study here concentrated on intracellular (nuclear) 
mechanisms of differentiation, it is also important to consider the 
roles of extracellular cues. In particular, the innate cytokines IL-1β  
and IL-23 drive the selective population expansion of IL-17+ γδ  
T cells in infection20, autoimmunity1 and tumor47 models. Our 
data showed selective epigenetic and transcriptional polarization of 
IL-1R1 and IL-23R in γδ27− T cells, which highlights the importance 
of these receptors in the biology of IL-17+ γδ T cells (but not IFN-γ+ γδ 
T cells). IL-1β and IL-23 also seemed to be key elements of the inflam-
matory milieu that triggered the plasticity of γδ27− T cell in vitro. 
In vivo, we detected that plasticity in the tumor microenvironment 
but not during systemic responses to infection. Notably, CD4+ T cells 
‘convert’ from TH17 cells to TH1 cells under IL-23-dependent inflam-
matory conditions in experimental autoimmune encephalomyelitis 
but not during acute cutaneous infection with Candida albicans, while 
in the same conditions, γδ T cells remain producers of IL-17 and do 
not acquire IFN-γ expression48. However, that does not indicate that 
microorganisms cannot trigger plasticity in γδ27− T cell, as it has been 
observed in gut-associated (mesenteric) lymph nodes after oral infec-
tion with Listeria49. Instead, we think this highlights the importance 
of the local inflammatory environment for the acquisition of IFN-γ 
expression by γδ27− T cells.
The epigenomic data on γδ T cell subsets presented here provides 
a framework for the analysis and interpretation of the functions of 
γδ27+ and γδ27− T cells in the periphery. In particular, we found that 
γδ27− T cells that acquired the ability to produce IL-17 during thymic 
development were nonetheless endowed with functional plasticity 
that allowed them to also produce IFN-γ under local inflammatory 
conditions. Future studies should determine the specific roles of 
IL-17+IFN-γ+ γδ cells in vivo models of infection, cancer or autoim-
munity. These cells have been observed in the central nervous sys-
tem of mice suffering experimental autoimmune encephalomyelitis 
(but not in healthy control mice)50 and may thus contribute to the 
pathogenic role of γδ T cells in this1 and other disease models.
METHODS
Methods and any associated references are available in the online 
version of the paper.
Accession codes. GEO: ChIP-seq data, GSE42098.
Note: Any Supplementary Information and Source Data files are available in the 
online version of the paper.
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ONLINE METHODS
Mice. All mice used were adults 6–12 weeks of age. C57BL/6, Tcra−/−, Rorc−/− 
and Tbx21−/− mice were from Jackson Laboratories. Slamf1−/− and Dkk3−/− 
mice were provided by C. Terhorst and B. Arnold, respectively. Mice were bred 
and maintained in the specific pathogen–free animal facilities of Instituto de 
Medicina Molecular (Lisbon, Portugal) or Queen Mary London University 
(London, UK). All experiments involving animals were done in compliance 
with the relevant laws and institutional guidelines and were approved by the 
ethics committees of Instituto de Medicina Molecular and Blizard Institute.
Cell sorting or analysis by flow cytometry. For cell surface staining, single-
cell suspensions were incubated for 15 min on ice with anti-FcγR (2.4G2; BD 
Pharmingen), and then for 30 min with saturating concentrations of the appro-
priate monoclonal antibody. The following monoclonal antibodies were used: 
eFluor 450–anti-CD4 (RM4-5), fluorescein isothiocyanate– or phycoeryth-
rin–anti-TCRγδ (GL3), peridinin chlorophyll protein–cyanine 5.5–anti-CD3ε 
(145.2C11), phycoerythrin–indotricarbocyanine–anti-CD27 (LG.7F9), allo-
phycocyanin–anti-CD25 (PC61 5.3), allophycocyanin–eFluor 780–anti-CD8 
(53-6.7; all from eBiosciences); and Alexa Fluor 647–anti-CCR6 (29-2L17; 
BD Pharmingen). For sorting of T cell subsets, lymphoid organs were pooled 
from four mice (quantitative RT-PCR) or eight mice (ChIP-qPCR or ChIP-
seq). Cells were sorted on FACSAria III (BD Biosciences) or were analyzed 
on a FACSFortessa or FACSCalibur (BD Biosciences) and data were analyzed 
with FlowJo software (Tree Star).
For intracellular cytokine staining, cells sorted by flow cytometry were stim-
ulated for 4 h at 37 °C with PMA (phorbol 12-myristate 13-acetate; 50 ng/mL) 
and ionomycin (1 µg/mL) (Sigma) with 10 µg/mL brefeldin A (Sigma) added 
during the final 2 h. Cells were stained (with antibodies identified above), 
fixed for 15 min at 4 °C with 2% paraformaldehyde, permeabilized for 30 min 
at room temperature with 0.5% saponin and 0.1% FCS in 2 mM EDTA-PBS in 
the presence of anti-FcγR (2.4G2; BD Pharmingen) and finally incubated for 
1 h at room temperature with fluorescein isothiocyanate–anti-IL-17 (17B7; 
eBiosciences) and allophycocyanin–anti-IFN-γ (XMG1.2; eBiosciences).
In vitro cell stimulation and polarization. CD27+ and CD27- γδ T cells were 
sorted by flow cytometry and subjected to various stimulation conditions for 
48 h; CD4+ T cell–polarization cultures were maintained for 6 d. For TH1 
culture conditions, cells were activated with plate-bound monoclonal anti-
body (mAb) to CD3ε (5 µg/ml; 145.2C11; eBiosciences) and soluble mAb 
to CD28 (1 µg/ml; 37.51; eBiosciences), in the presence of IL-12 (5 ng/ml) 
and neutralizing mAb to IL-4 (10 µg/ml; 11B11; eBiosciences). For TH17 cul-
ture conditions, cells were activated with plate-bound anti-CD3ε, and soluble 
anti-CD28 and TGF-β (2 ng/ml), IL-1β (10 ng/ml), IL-6 (20 ng/ml), IL-21 
(100 ng/ml), IL-23 (10 ng/ml) and neutralizing anti-IFN-γ (10 µg/ml) were 
added to the medium. Alternatively, cells were incubated on plate-bound mAb 
to CD3ε (5 µg/ml), in the presence or absence of mouse IL-7 (10 ng/ml) or 
IL-1β plus IL-23 (both at 10 ng/ml).
ChIP-seq and ChIP-qPCR. Cells were sorted by flow cytometry from the 
thymus or pooled spleen and lymph nodes for ChIP. The following antibodies 
were used: antibody to histone H3 (ab1791; Abcam), antibody to H3K36me3 
(ab9050; Abcam), antibody to acetylated histone H3 (06-599; Millipore), 
antibody to H3K4me2 (07-030; Millipore) and antibody to H3K27me3 
(07-449; Millipore).
Cells (1 × 105 to 1 × 106) were crosslinked with formaldehyde and nuclei were 
isolated and sonicated with a Sanyo Soniprep 150 at an amplitude of 10 mm 
with 17 bursts of 10 s, which resulted in chromatin fragments 200–400 bp in 
length. Chromatin was immunoprecipitated as described51. The immuno-
precipitated DNA released from crosslinked proteins was extracted with a 
QiaQuick kit in accordance with the manufacturer’s instructions (Qiagen).
Deep sequencing was done at the GeneCore facility of the European 
Molecular Biology Laboratory. At least 1 ng of immunoprecipitated DNA was 
used for library preparation according to the Illumina protocol.
Alternatively, candidate genes were analyzed by ChIP-qPCR (primers, 
Supplementary Table 3).
The occupancy of the immunoprecipitated protein at each DNA site 
was estimated as follows: 2(Cspecific − CtotalH3) where, Cspecific and C totalH3 are 
threshold cycles of PCR of DNA from specific immunoprecipitation or total 
H3 immunoprecipitation, respectively.
ChIP-seq data analysis. High-throughput sequencing ‘reads’ were aligned to 
the reference mouse genome (the mm9 assembly of the National Center for 
Biotechnology Information) with Bowtie software for the alignment of short 
DNA sequences52. ‘Read’ quality was assessed with the FastQC quality-control 
tool for high throughput sequence data (Babraham Bioinformatics). ‘Reads’ with 
bad-quality scores, ‘reads’ not uniquely mapped and PCR duplicates (identical 
coordinates) were filtered out. The SAMtools utility for storing large nucleotide 
sequence alignments and manipulating alignments53 and BEDtools software 
for the comparison of genomic features54 were used for filtering steps and file 
format conversion. Three different peak-calling tools (MACS55,56, SICER57 
and RSEG58) were used for the detection of enrichment of histone modifi-
cations density. The recommended settings for histone modifications were 
used for these analyses, and only peaks that were consistently detected by the 
three methods were considered. Regions with different histone-modification 
densities in two samples were identified with the submodule of SICER57, with 
a false-discovery rate of 0.05 and absolute change in density >1.5-fold.
Regions with enrichment were then assigned to known genes of the UCSC 
Genome Browser, including a 1-kilobase region upstream of transcription 
start site (the mm9 assembly of the mouse genome of the National Center for 
Biotechnology Information)59.
For quantitative calculation and profiles of histone modifications for all 
genes, uniquely mapped ‘reads’ were extended in the 3′ direction to reach 
150 nt with the Pyicos deep-sequencing analysis tool60. Only ‘read’ counts 
that overlapped histone-enriched regions identified above were considered. 
The quantitative results per gene were log10-transformed. For genes without 
enriched regions, the amount was defined as 0.
For average profiles across genes with differences in histone densities, 
a ‘metagene’ profile was plotted for each gene group. Genes were aligned at 
the first and last nucleotides of the annotated transcripts and sequencing tags 
were scaled as follows: the 5′ end (2 kb upstream of the transcription start site 
to 1 kb downstream) and the 3′ end (500 bp upstream of the poly(A) site to 
1 kb downstream) were unscaled and averaged in a 10-bp window, and the 
remainder of the gene was scaled to 200 bins of equal size so that all genes 
seem to have the same length (2 kb). Individual profiles were produced with 
a window of 5 bp. All profiles were plotted on a normalized reads-per-million 
basis. The processed data were plotted and visualized using software of the 
R project for statistical computing61.
Real-time PCR. Cell populations were sorted by flow cytometry and mRNA 
was prepared from those with a High Pure RNA Isolation kit (Roche). 
Random oligonucleotides (Invitrogen) and MMLV reverse transcriptase 
(Promega) were used for reverse transcription for 1 h at 42 °C. SYBR or 
TaqMan probe chemistry on an ABI ViiA7 cycler (Applied Biosystems) was 
used for quantification of specific cDNA species relative to that of Actb. 
The cycling threshold (Ct) for the target gene was subtracted from that of 
Actb and the relative amount was calculated as 2−∆Ct. Primers were designed 
with Primer Express software (Applied Biosystems) and their sequences 
were as follows: Actb forward, CGTGAAAAGATGACCCAGATCA, and 
reverse, TGGTACGACCAGAGGCATACAG; Blk forward, TTATGTGC 
CCAGCAACTTTGTG, and reverse, AAGGCACCTTTATTGCTCTCA 
CTCT; Eomes forward, CGTTCACCCAGAATCTCCTAACA, and reverse, 
TGCAGCCTCGGTTGGTATTT; Hlx forward, AGCTCCAACCCAAGA 
AATTCTGT, and reverse, GCTTGTATGTCTGTGGCATGGT; probe, ACA 
CATTTCCAGGTCCCTATGCTGTGCTC; Ifng forward, TCTTCTTGG
ATATCTGGAGGAACTG, and reverse, GAGATAATCTGGCTCTGCAG
GATT; Il17a forward, CCAGAAGGCCCTCAGACTACCT, and reverse, 
TCCCTCCGCATTGACACA; Il17f forward, CAACCAAAACCAGGGCATTT, 
and reverse, ACTGGGCCTCAGCGATCTCT; Il22 forward, GTGCCTTT 
CCTGACCAAACT, and reverse, CTGTCTCCTTCAGCCTTCTG; Il23r  
forward, TCAGTGCTACAATCTTCAGAGGACA, and reverse, GCCAA 
GAAGACCATTCCCGA; Maf forward, AGCAGGTAGACCACCTCAA 
GCA, and reverse, GAGTCCCTTGGGTACATGAAAAATT; Rora forward, 
TCCCCTACTGTTCCTTCACCAA, and reverse, GGAAGGTCTGCCACG 
TTATCTG; Rorc forward, GTCCAGACAGCCACTGCATTC, and reverse, 
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TGCGCTGCCGTAGAAGGT; Runx3 forward, ACTGGCGCTGCAACAA 
GAC, and reverse, GGCCCACGAATCGAAGGT; and Tbx21 forward, 
CACACACGTCTTTACTTTCCAAGAGA, and reverse, CACTCGTATCAA
CAGATGCGTACAT.
Tumor transplantation. ID8 ovarian cancer cells (provided by K. Roby) 
were injected intraperitoneally into C57BL/6 female mice (5 × 106 cells per 
mouse). Tumor growth was monitored as described38. Peritoneal exudate cells 
were collected 2–6 weeks after tumor transplantation, then were stimulated 
in vitro for 4 h with PMA and ionomycin and stained intracellularly for IL-17 
and IFN-γ.
Infection. Mice were infected intraperitoneally with 1 × 106 red blood cells 
infected with Plasmodium berghei ANKA with transgenic expression of GFP 
(provided by A. Pamplona) and were monitored as previously described10. 
Cells from the spleen and lymph nodes were collected for analysis after 3 d.
Mice were infected intraperitoneally with 1 × 106 plaque-forming units of 
murid herpes virus 4 (provided by P. Simas), and cells from the spleen and 
lymph nodes were collected after 14 d.
Mice were infected intravenously with 1 × 106 colony-forming units of 
Mycobacterium avium strain 2447 (provided by M. Correia-Neves). Cells from 
the spleen and lymph nodes were collected 17 d after infection. Infection was 
confirmed by serial dilutions of homogenized spleen plated onto Middlebrook 
7H10 agar.
Mice were infected intravenously with 1 × 105 live Candida albicans yeast 
strain WT-SC 3314 (provided by C. Reis e Sousa). Cells from the spleen and 
lymph nodes were collected 7 d after infection. Infection was confirmed by 
serial dilutions of homogenized kidney suspension plated onto yeast extract 
peptone dextrose agar medium.
Statistical analysis. A two-tailed non-parametric Mann-Whitney test was 
used for statistical analysis. P values of <0.05 were considered significant.
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